ENTERPRISE THERAPEUTICS LTD
Significant control: Enterprise Therapeutics Holdings Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Enterprise Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Enterprise Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ENTERPRISE THERAPEUTICS LTD is an active private limited company (company number 09022750) incorporated on 2 May 2014, registered in Brighton. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest full accounts cover the period ending 30 June 2025, showing net assets of −£17.23m, with 9 employees on average. Net assets fell 33% on the prior period (−£12.93m).
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Enterprise Therapeutics Holdings Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Touchstone Innovations Businesses Llp
- owns 25–50% of shares
- holds 25–50% of voting rights
- Epidarex Capital Partners Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- Ip2ipo Portfolio (Gp) Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 2 May 201412 yrs ago
- Next accounts due
- 30 March 2027in 153 days
- Confirmation statement due
- 16 May 2027in 200 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | −£17.23m | — | — | — | — | −£4.32m | 9 |
| 31 December 2024 | −£12.93m | — | — | — | — | −£7.22m | 8 |
| 1 January 2024 | — | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-17,229,752 at 30 June 2025
- Net assets down 25% or more on the prior period-33.3% vs prior period
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 2 May 2014
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 200 days
- Next accounts duein 153 days
- Accounts period endNet liabilities £17.23m · full accounts
- Accounts period endNet liabilities £12.93m · full accounts
- Accounts period end
- Incorporated
Similar companies in Brighton
- BENCHMARK GENETICS LIMITEDWorthing · inc. Jul 2014
- BIOPROBE LIMITEDLittlehampton · inc. Jan 2014
- FORWARD HORTICULTURE CONSULTING LIMITEDWorthing · inc. Nov 2012
- OPTCEUTICS LIMITEDBrighton · inc. Feb 2016
- MULLBIOLOGICS CONSULTANCY LTDLittlehampton · inc. May 2012
- SLANTEC LIMITEDHassocks · inc. Apr 2012
All companies incorporated on 2 May 2014 · in May 2014.
Reminders for ENTERPRISE THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.